531 related articles for article (PubMed ID: 28120842)
1. Gut permeability and mucosal inflammation: bad, good or context dependent.
Ahmad R; Sorrell MF; Batra SK; Dhawan P; Singh AB
Mucosal Immunol; 2017 Mar; 10(2):307-317. PubMed ID: 28120842
[TBL] [Abstract][Full Text] [Related]
2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
3. Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis.
He L; Liu T; Shi Y; Tian F; Hu H; Deb DK; Chen Y; Bissonnette M; Li YC
Endocrinology; 2018 Feb; 159(2):967-979. PubMed ID: 29228157
[TBL] [Abstract][Full Text] [Related]
4. Immunity, inflammation, and allergy in the gut.
Macdonald TT; Monteleone G
Science; 2005 Mar; 307(5717):1920-5. PubMed ID: 15790845
[TBL] [Abstract][Full Text] [Related]
5. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
6. Immunopathology of inflammatory bowel disease.
Wallace KL; Zheng LB; Kanazawa Y; Shih DQ
World J Gastroenterol; 2014 Jan; 20(1):6-21. PubMed ID: 24415853
[TBL] [Abstract][Full Text] [Related]
7. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
Jackson DN; Theiss AL
Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity.
Zhang Z; Tanaka I; Nakahashi-Ouchida R; Ernst PB; Kiyono H; Kurashima Y
Semin Immunopathol; 2024 Jan; 45(4-6):493-507. PubMed ID: 38170255
[TBL] [Abstract][Full Text] [Related]
9. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
Zhou GX; Liu ZJ
J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
[TBL] [Abstract][Full Text] [Related]
10. The crosstalk between gut bacteria and host immunity in intestinal inflammation.
Yang Q; Wang Y; Jia A; Wang Y; Bi Y; Liu G
J Cell Physiol; 2021 Apr; 236(4):2239-2254. PubMed ID: 32853458
[TBL] [Abstract][Full Text] [Related]
11. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut.
Michielan A; D'Incà R
Mediators Inflamm; 2015; 2015():628157. PubMed ID: 26582965
[TBL] [Abstract][Full Text] [Related]
12. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
Schoultz I; Keita ÅV
Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
[TBL] [Abstract][Full Text] [Related]
13. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
Valatas V; Kolios G; Bamias G
Front Immunol; 2019; 10():583. PubMed ID: 30972074
[TBL] [Abstract][Full Text] [Related]
14. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis.
Ahmad R; Chaturvedi R; Olivares-Villagómez D; Habib T; Asim M; Shivesh P; Polk DB; Wilson KT; Washington MK; Van Kaer L; Dhawan P; Singh AB
Mucosal Immunol; 2014 Nov; 7(6):1340-53. PubMed ID: 24670427
[TBL] [Abstract][Full Text] [Related]
15. The acetylome regulators Hdac1 and Hdac2 differently modulate intestinal epithelial cell dependent homeostatic responses in experimental colitis.
Turgeon N; Gagné JM; Blais M; Gendron FP; Boudreau F; Asselin C
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G594-605. PubMed ID: 24525021
[TBL] [Abstract][Full Text] [Related]
16. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.
Zhang H; Xue Y; Wang H; Huang Y; Du M; Yang Q; Zhu MJ
World J Gastroenterol; 2014 Jul; 20(27):9106-15. PubMed ID: 25083083
[TBL] [Abstract][Full Text] [Related]
17. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
18. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease.
Jergens AE; Parvinroo S; Kopper J; Wannemuehler MJ
Front Med (Lausanne); 2021; 8():669913. PubMed ID: 34513862
[TBL] [Abstract][Full Text] [Related]
19. The effects and mechanisms of myeloid differentiation protein 2 on intestinal mucosal permeability in mice with chronic colitis.
Han C; Guan Q; Guo L; Yang Y; Ruan S; Zhang X
J Cell Physiol; 2019 Nov; 234(11):21089-21099. PubMed ID: 31032920
[TBL] [Abstract][Full Text] [Related]
20. Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis.
Khounlotham M; Kim W; Peatman E; Nava P; Medina-Contreras O; Addis C; Koch S; Fournier B; Nusrat A; Denning TL; Parkos CA
Immunity; 2012 Sep; 37(3):563-73. PubMed ID: 22981539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
